We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.33B
AUM Growth
+$1.69B
Cap. Flow
+$1.15B
Cap. Flow %
15.72%
Top 10 Hldgs %
11.92%
Holding
611
New
202
Increased
183
Reduced
174
Closed
49

Top Sells

Rank Stock Value
1
DT icon
Dynatrace
DT
+$106M
2
SPXC icon
SPX Corp
SPXC
+$28.8M
3
EQC
Equity Commonwealth
EQC
+$25.2M
4
GIL icon
Gildan
GIL
+$24.7M
5
ICUI icon
ICU Medical
ICUI
+$17.3M

Sector Composition

Rank Sector Weight
1 Industrials 19.48%
2 Technology 18.29%
3 Financials 14.4%
4 Healthcare 13.59%
5 Consumer Discretionary 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFLX icon
76
Netflix
NFLX
$299B
$29M 0.4%
+408,390
New +$27.3M
ITT icon
77
ITT
ITT
$17.5B
$28.8M 0.39%
192,485
+6,552
+4% +$892K
AGI icon
78
Alamos Gold
AGI
$11.6B
$28.6M 0.39%
1,434,876
-53,909
-4% -$989K
KRYS icon
79
Krystal Biotech
KRYS
$10.1B
$28.6M 0.39%
157,144
+122,407
+352% +$23.6M
SXT icon
80
Sensient Technologies
SXT
$5.26B
$28.6M 0.39%
356,501
-72,718
-17% -$5.52M
NEO icon
81
NeoGenomics
NEO
$1.96B
$27.9M 0.38%
1,893,407
+759,524
+67% +$11.9M
CBU icon
82
Community Bank
CBU
$3.41B
$27.9M 0.38%
479,845
-18,267
-4% -$1.05M
GMED icon
83
Globus Medical
GMED
$10.7B
$27.7M 0.38%
387,737
+26,047
+7% +$1.84M
TMO icon
84
Thermo Fisher Scientific
TMO
$213B
$27.7M 0.38%
44,701
+24,170
+118% +$14.3M
MRVL icon
85
Marvell Technology
MRVL
$168B
$27.6M 0.38%
382,288
+21,985
+6% +$1.52M
SHOO icon
86
Steven Madden
SHOO
$3.37B
$27.5M 0.37%
560,424
-10,209
-2% -$453K
MOD icon
87
Modine Manufacturing
MOD
$10.7B
$27.2M 0.37%
204,512
-4,250
-2% -$470K
VRTX icon
88
Vertex Pharmaceuticals
VRTX
$121B
$26.9M 0.37%
+57,825
New +$27.8M
CDNS icon
89
Cadence Design Systems
CDNS
$93.6B
$25.8M 0.35%
95,014
+48,886
+106% +$13.5M
DIVB icon
90
iShares Core Dividend ETF
DIVB
$1.69B
$25.7M 0.35%
+529,863
New +$24.6M
UL icon
91
Unilever
UL
$137B
$25.5M 0.35%
349,588
+21,864
+7% +$1.51M
CHDN icon
92
Churchill Downs
CHDN
$5.88B
$25.5M 0.35%
188,358
-44,821
-19% -$6.2M
STE icon
93
Steris
STE
$22.3B
$25.1M 0.34%
103,547
+5,506
+6% +$1.29M
ORLY icon
94
O'Reilly Automotive
ORLY
$72.9B
$25M 0.34%
325,695
+110,100
+51% +$8.09M
MTRN icon
95
Materion
MTRN
$4.39B
$24.7M 0.34%
221,086
+11,198
+5% +$1.25M
GWRE icon
96
Guidewire Software
GWRE
$12.6B
$23.1M 0.31%
126,133
+2,418
+2% +$367K
PLXS icon
97
Plexus
PLXS
$6.72B
$23M 0.31%
168,169
-75,443
-31% -$9.16M
LIN icon
98
Linde
LIN
$221B
$22.9M 0.31%
+48,053
New +$21.9M
OLED icon
99
Universal Display
OLED
$3.68B
$22.9M 0.31%
109,030
+19,002
+21% +$3.85M
OGE icon
100
OGE Energy
OGE
$9.78B
$22.8M 0.31%
556,616
-47,248
-8% -$1.83M

Similar funds

Segall Bryant & Hamill's Q3 2024 Portfolio in Review

As of Q3 2024, Segall Bryant & Hamill held 611 positions worth $7.33B, up 30% from $5.64B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Segall Bryant & Hamill deployed $1.15B of net new capital in Q3 2024, opening 202 new positions and adding to 183 existing holdings. Its largest new stake was NVIDIA: 687,551 shares worth $83.5M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was SPX Corp, an estimated $28.8M trimmed.

  • Segall Bryant & Hamill's largest Q3 2024 buy was NVIDIA: 687,551 shares worth $83.5M.
  • Segall Bryant & Hamill added most to Microsoft in Q3 2024, an estimated $91.1M increase.
  • Segall Bryant & Hamill's biggest Q3 2024 reduction was SPX Corp, cutting an estimated $28.8M.
  • Segall Bryant & Hamill fully exited Dynatrace in Q3 2024, selling an estimated $106M.
  • Segall Bryant & Hamill's ten largest holdings make up 12% of its $7.33B portfolio in Q3 2024.
  • Segall Bryant & Hamill opened 202 new positions and closed 49 in Q3 2024.
  • Segall Bryant & Hamill's portfolio value rose 30% quarter-over-quarter to $7.33B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2024, filed 8 Nov 2024.